Finland's Medisize to increase production of components for Sanofi-aventis insulin pens

21-Feb-09
Medisize, a European manufacturer of medical & diagnostic devices and pharma- packaging, has announced to set up additional capacity at its Kontiolahti (Finland) plant for production of components used in Sanofi-aventis insulin injection pens. Sanofi-aventis insulin injection pens offer diabetes patients a convenient way to manage their condition. Finland-headquartered Medisize has been involved in the pen components production line for Sanofi-aventis and worked in very close cooperation with the customer for manufacturing, tooling design, moulding and automatic assembly. The capacity addition project underlines the long-term partnership between Medisize and Sanofi-aventis.
  More News  Post Your Comment

Previous News

Next News

{{comment.Name}} made a post.
{{comment.DateTimeStampDisplay}}

{{comment.Comments}}

COMMENTS

0

There are no comments to display. Be the first one to comment!

*

Name Required.

*

Email Id Required.

Email Id Not Valid.

*

Mobile Required.

Email ID and Mobile Number are kept private and will not be shown publicly.
*

Message Required.

Click to Change image  Refresh Captcha